Pfizer COVID-19 vaccine appointments are available to our patients. Sign up for Connect today to schedule your vaccination. Continue your routine care with us by scheduling an in-person appointment or Video Visit.

Microglial NF-κB drives tau spreading and toxicity in a mouse model of tauopathy.

TitleMicroglial NF-κB drives tau spreading and toxicity in a mouse model of tauopathy.
Publication TypeJournal Article
Year of Publication2022
AuthorsWang C, Fan L, Khawaja RR, Liu B, Zhan L, Kodama L, Chin M, Li Y, Le D, Zhou Y, Condello C, Grinberg LT, Seeley WW, Miller BL, Mok S-A, Gestwicki JE, Cuervo AMaria, Luo W, Gan L
JournalNat Commun
Volume13
Issue1
Pagination1969
Date Published2022 Apr 12
ISSN2041-1723
KeywordsAnimals, Mice, Microglia, NF-kappa B, Tauopathies
Abstract

Activation of microglia is a prominent pathological feature in tauopathies, including Alzheimer's disease. How microglia activation contributes to tau toxicity remains largely unknown. Here we show that nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) signaling, activated by tau, drives microglial-mediated tau propagation and toxicity. Constitutive activation of microglial NF-κB exacerbated, while inactivation diminished, tau seeding and spreading in young PS19 mice. Inhibition of NF-κB activation enhanced the retention while reduced the release of internalized pathogenic tau fibrils from primary microglia and rescued microglial autophagy deficits. Inhibition of microglial NF-κB in aged PS19 mice rescued tau-mediated learning and memory deficits, restored overall transcriptomic changes while increasing neuronal tau inclusions. Single cell RNA-seq revealed that tau-associated disease states in microglia were diminished by NF-κB inactivation and further transformed by constitutive NF-κB activation. Our study establishes a role for microglial NF-κB signaling in mediating tau spreading and toxicity in tauopathy.

DOI10.1038/s41467-022-29552-6
Alternate JournalNat Commun
PubMed ID35413950